Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema
- DOI
- 10.1001/jamaophthalmol.2015.4110
- Published
- 2016-01-01
- Container
- JAMA Ophthalmology
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamaophthalmol.2015.4110,
title = {Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema},
author = {Jeffrey S. Heier and Neil M. Bressler and Robert L. Avery and Sophie J. Bakri and David S. Boyer and David M. Brown and Pravin U. Dugel and K. Bailey Freund and Adam R. Glassman and Judy E. Kim and Daniel F. Martin and John S. Pollack and Carl D. Regillo and Philip J. Rosenfeld and Andrew P. Schachat and John A. Wells and Unknown},
year = {2016},
journal = {JAMA Ophthalmology},
doi = {10.1001/jamaophthalmol.2015.4110},
url = {https://doi.org/10.1001/jamaophthalmol.2015.4110}
}RIS
TY - JOUR TI - Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema AU - Jeffrey S. Heier AU - Neil M. Bressler AU - Robert L. Avery AU - Sophie J. Bakri AU - David S. Boyer AU - David M. Brown AU - Pravin U. Dugel AU - K. Bailey Freund AU - Adam R. Glassman AU - Judy E. Kim AU - Daniel F. Martin AU - John S. Pollack AU - Carl D. Regillo AU - Philip J. Rosenfeld AU - Andrew P. Schachat AU - John A. Wells AU - Unknown PY - 2016 JO - JAMA Ophthalmology DO - 10.1001/jamaophthalmol.2015.4110 UR - https://doi.org/10.1001/jamaophthalmol.2015.4110 ER -
APA
Heier, J. S., Bressler, N. M., Avery, R. L., Bakri, S. J., Boyer, D. S., Brown, D. M., Dugel, P. U., Freund, K. B., Glassman, A. R., Kim, J. E., Martin, D. F., Pollack, J. S., Regillo, C. D., Rosenfeld, P. J., Schachat, A. P., Wells, J. A., & Unknown (2016). Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema. JAMA Ophthalmology. https://doi.org/10.1001/jamaophthalmol.2015.4110
Source records
- crossref · retrieved 2026-09-26T22:10:30.371Z